Azacitidine
- Product NDC
- 51991-797
- 11-digit product format
- 519910797
- Labeler code
- 51991
- Product ID
- 51991-797_1ba11f6a-c960-4e56-9f71-fdc972d990db
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Azacitidine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Application
- ANDA207234
- Marketing category
- ANDA
- Marketing start
- 2017-06-23
- Marketing end
- 2024-01-31
- Substance
- AZACITIDINE
- Active strength
- 100 mg/50mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51991-797-98 | 51991079798 | 1 VIAL, SINGLE-DOSE in 1 CARTON (51991-797-98) > 50 mL in 1 VIAL, SINGLE-DOSE | 2017-08-07 | 0000-00-00 | No | No | Current |